Syndax Pharmaceuticals
SNDX
SNDX
136 hedge funds and large institutions have $943M invested in Syndax Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 23 closing their positions.
Holders
136
Holders Change
+4
Holders Change %
+3.03%
% of All Funds
2.15%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
27
Increased
53
Reduced
31
Closed
23
Calls
$1.56M
Puts
$21K
Net Calls
+$1.53M
Net Calls Change
-$3.41M
Top Buyers
| 1 |
KCM
1
Kynam Capital Management
Princeton,
New Jersey
|
$33.6M |
| 2 |
2
Morgan Stanley
New York
|
$12.1M |
| 3 |
3
Millennium Management
New York
|
$7.41M |
| 4 |
BI
4
BVF Inc
San Francisco,
California
|
$41.6M |
| 5 |
PBA
5
Paradigm Biocapital Advisors
New York
|
$12.2M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Jane Street
New York
| – | – | -21,778 | Closed |
|
|
SSA
152
Schonfeld Strategic Advisors
New York
| – | – | -12,300 | Closed |
|
|
BAM
153
Blueshift Asset Management
Red Bank,
New Jersey
| – | – | -9,860 | Closed |
|
154
Optiver Holding
Amsterdam,
Netherlands
| – | – | -5,147 | Closed |
|
|
CCA
155
Cross Creek Advisors
Salt Lake City,
Utah
| – | – | -2,649 | Closed |
|
|
ACM
156
Aquatic Capital Management
Chicago,
Illinois
| – | – | -500 | Closed |
|
|
CAC
157
Cowen and Company
New York
| – | – | -377 | Closed |
|
|
PA
158
Parallel Advisors
San Francisco,
California
| – | – | -13 | Closed |
|
|
CCMW
159
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
| – | – | -5 | Closed |
|
|
CFGS
160
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
161
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
SM
162
SG3 Management
Dorado,
Puerto Rico
| – | – | – | – |
|
|
C
163
Covestor
London,
United Kingdom
| – | – | – | – |
|